The Turenne Group has been present in the Rhône-Alpes-Auvergne region since 2014.
Over the last 15 years, as an investor specialising in venture capital, growth capital and buyout capital, we have worked in the region with a number of regional companies, such as Alizé Pharma (biotech), Aston Medical (implantology), Biom’up (biotech), Eyetechcare (ultrasound glaucoma treatment), Menix (protheses), Sword (IT consulting) and Axemble (product lifecycle management solutions integrator).
Our team in Lyon provides venture, growth and buyout capital to companies in the region.
We acquire minority and majority stakes with ticket sizes of €1 million to €10 million with the Group’s sector funds. Our types of investment are as follows:
Created in July 2014, Sham Innovation Santé is an SCR (French venture capital company or “Société de Capital Risque”), a subsidiary of Sham (part of mutualist group Relyens), advised by the Turenne Group since May 2014 and dedicated to investment in innovative companies, particularly in biotech and medical devices.